Welcome Guest
Home > Clinical Genitourinary Cancer > Volume 4 |  Issue 3

Table of Contents

Volume 4 |  Issue 3

Publication Date: December 2005
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorials
Page Number of this Article in the Print Version
154		 Clinical Genitourinary Cancer: A Broadening of Scope
Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
155		 Renal Cell Carcinoma: A New Era?
Ronald M. Bukowski
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
156-159		 Highlights from: the International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications; Philadelphia, PA; November 2005; ECCO 13–The European Cancer Conference; Paris, France; October 30 - November 3, 2005
Kesava Reddy, Amy D’Orazio, Eric Nadler, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Reviews
Page Number of this Article in the Print Version
160-166		 Perioperative Complications of Radical Retropubic Prostatectomy
Joseph R. Sterbis, Stephen A. Brassell, David G. McLeod
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
167-174		 Sorafenib: Scientific Rationales for Single-Agent and Combination Therapy in Clear-Cell Renal Cell Carcinoma
Jared A. Gollob
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
175-180		 SU11248 and AG013736: Current Data and Future Trials in Renal Cell Carcinoma
Brian I. Rini
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
181-186		 Cytokine Therapy: A Standard of Care for Metastatic Renal Cell Carcinoma?
Thomas E. Hutson, David I. Quinn
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
187-192		 Prostate Cancer Therapy with High-Intensity Focused Ultrasound
Thomas A. Gardner, Michael O. Koch
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
193-196		 What Constitutes High-Risk Locally Advanced Prostate Cancer?
Heather D. Mannuel, Arif Hussain
  • Abstract
  • No Access
  • Add to Cart
Translational Medicine
Page Number of this Article in the Print Version
197-202		 Antiangiogenesis: A Possible Treatment Option for Prostate Cancer?
Ritchie L. Longoria, Michael C. Cox, William D. Figg
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
203-211		 Cyclooxygenase-2: A Therapeutic Target for Prostate Cancer
Raj S. Pruthi, Eric M. Wallen
  • Abstract
  • No Access
  • Add to Cart
Current Trials
Page Number of this Article in the Print Version
212-214		 Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Chemotherapy with Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer
Asmita R. Patel, Howard M. Sandler, Kenneth J. Pienta
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
215-218		 A Phase I Study of a DNA Vaccine Targeting Prostatic Acid Phosphatase in Patients with Stage D0 Prostate Cancer
Sarah Zlotocha, Mary Jane Staab, Dorothy Horvath, Jane Straus, Jeanne Dobratz, Katherine Oliver, Stephine Wasielewski, Dona Alberti, Glenn Liu, George Wilding, Jens Eickhoff, Douglas G. McNeel
  • Abstract
  • No Access
  • Add to Cart
Clinical Trials
Page Number of this Article in the Print Version
219		 Selected Clinical Trails in Prostate Cancer
CIG Media Group
  • Abstract
  • No Access
  • Add to Cart